Why the study?
Due to clinical heterogeneity and single-center studies with limited patient numbers, dedicated guidelines are lacking for severity assessment and clinical decision-making in multiple and mixed valvular heart disease.
This review highlights the diagnostic challenges of multiple and mixed valvular heart disease and emphasizes the role of multimodality imaging for accurate severity assessment and prognosis.
Answers are grounded in this paper and cite their sources.
Multimodality imaging may aid assessment in mixed valvular disease; leaves open prospective validation of protocols and outcomes.
Multiple and mixed valvular heart disease (MMVD) is defined as the combination of stenotic or regurgitant lesions occurring on ≥2 cardiac valves (ie, multiple valvular heart disease [VHD]) or the combination of stenotic and regurgitant lesions on the same valve (ie, mixed VHD). This condition is frequent in clinical routine, with a notable shift in epidemiology over recent years, marked by a decline in rheumatic heart disease and an increase in degenerative causes. Even if echocardiography stands as the cornerstone for diagnosing VHD, practicians need to remain cautious because some echocardiographic parameters might be invalid in the context of MMVD. Considering echocardiography's pitfalls, MMVD needs to be assessed using multiparametric perspective, including cardiovascular magnetic resonance, cardiac computed tomography, biomarkers, and the assessment of comorbidities. Multimodality imaging seems to be a promising approach to assess patient's prognosis, by providing a precise analysis of cardiac remodeling and an accurate evaluation of MMVD severity. Due to the heterogeneity of this clinical scenario, studies are typically conducted in single centers with a limited number of patients. Therefore, there is a lack of dedicated guidelines regarding the severity assessment and the clinical decision-making for these MMVD patients. The aim of this review is to provide a state-of-the-art using the available evidence on the management of MMVD considering the interactions between different valve lesions, the diagnostic pitfalls, and the strategies that should be considered including the role of multimodality imaging in the presence of MMVD.
No takes yet. Share an insight, caveat, or question.
Vesvrotte et al. (2025) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: